Finance
Home health business grows; Probactrix update provided
Published in AIDS Weekly, September 15th, 2003
Net sales were $10,820,960 and were entirely generated from its healthcare services subsidiary. The company's BioBalance subsidiary is a developmental stage specialty pharmaceutical company which did not generate revenues during this period.
For the second quarter, the company recorded a net loss of $689,088 or $0.03 per share. This compares to a loss of $338,475 for the year-ago period. The loss is due primarily to research-related expenses within the BioBalance subsidiary for development and testing of its proprietary biotherapeutic agent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-09-15)
More Articles from AIDS Weekly
- HIV/AIDS Therapy
Anti-nerve growth factor antibody shows promise for HIV control - HIV/AIDS Therapy
RNA-based gene therapy techniques show promise for HIV control - Cardiovascular Disease
Young HIV patients have increased heart disease risk - HIV Progression
Six months after start of treatment could be optimum time for making prognosis - HIV/AIDS
Importin 7 mediates nuclear import of HIV intracellular reverse transcription complexes - HIV/AIDS Immunology
CD4+ natural killer cells may play key role in HIV pathogenesis - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
